Companies: 10,795·Total market cap: $144.5T
Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.

HALONASDAQHealthcare● Active
$71.00
$-0.53(-0.74%)
Market Cap$8.4B
P/E Ratio
52W High$82.22
52W Low$51.06

Halozyme Therapeutics, Inc. (HALO) Stock Splits

No forward or reverse splits on record since IPO — details below.

FMP · HALO · as of Jun 8, 2026

Key split metrics

Halozyme Therapeutics, Inc. (HALO) has been publicly traded since Mar 16, 2004 with no forward or reverse splits on record.

About stock split history

Halozyme Therapeutics, Inc. (HALO) has never undergone a stock split since going public.

Frequently asked questions

Halozyme Therapeutics, Inc. (HALO) has never split its stock since going public.

HALO stock split historyhas HALO ever stock splitno stock split since IPO
Data: Financial Modeling Prep · Updated daily · For informational purposes only, not investment advice.